David Dickason
Corporate Officer/Principal chez RESPIRERX PHARMACEUTICALS INC.
Fortune : - $ au 30/06/2024
Profil
David Dickason is currently the Senior VP-Pre-Clinical Product Development at RespireRx Pharmaceuticals, Inc. He previously worked as the Director-Formulation Development at GTx, Inc. from 2006 to 2010 and as the Vice President-Technical Development at Iroko Pharmaceuticals LLC from 2010 to 2016.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/04/2023 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de David Dickason
| Sociétés | Poste | Début |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Corporate Officer/Principal | 15/09/2020 |
Anciens postes connus de David Dickason
| Sociétés | Poste | Fin |
|---|---|---|
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Directeur Technique/Scientifique/R&D | 01/01/2016 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Corporate Officer/Principal | 01/01/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Iroko Pharmaceuticals LLC
Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Health Technology |
